Laparoscopic Liver Resection: A South American Experience with 2887 Cases.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
Nov 2020
Historique:
pubmed: 28 6 2020
medline: 25 6 2021
entrez: 28 6 2020
Statut: ppublish

Résumé

Laparoscopic liver resections (LLR) have been increasingly performed in recent years. Most of the available evidence, however, comes from specialized centers in Asia, Europe and USA. Data from South America are limited and based on single-center experiences. To date, no multicenter studies evaluated the results of LLR in South America. The aim of this study was to evaluate the experience and results with LLR in South American centers. From February to November 2019, a survey about LLR was conducted in 61 hepatobiliary centers in South America, composed by 20 questions concerning demographic characteristics, surgical data, and perioperative results. Fifty-one (83.6%) centers from seven different countries answered the survey. A total of 2887 LLR were performed, as follows: Argentina (928), Brazil (1326), Chile (322), Colombia (210), Paraguay (9), Peru (75), and Uruguay (8). The first program began in 1997; however, the majority (60.7%) started after 2010. The percentage of LLR over open resections was 28.4% (4.4-84%). Of the total, 76.5% were minor hepatectomies and 23.5% major, including 266 right hepatectomies and 343 left hepatectomies. The conversion rate was 9.7%, overall morbidity 13%, and mortality 0.7%. This is the largest study assessing the dissemination and results of LLR in South America. It showed an increasing number of centers performing LLR with the promising perioperative results, aligned with other worldwide excellence centers.

Sections du résumé

BACKGROUND BACKGROUND
Laparoscopic liver resections (LLR) have been increasingly performed in recent years. Most of the available evidence, however, comes from specialized centers in Asia, Europe and USA. Data from South America are limited and based on single-center experiences. To date, no multicenter studies evaluated the results of LLR in South America. The aim of this study was to evaluate the experience and results with LLR in South American centers.
METHODS METHODS
From February to November 2019, a survey about LLR was conducted in 61 hepatobiliary centers in South America, composed by 20 questions concerning demographic characteristics, surgical data, and perioperative results.
RESULTS RESULTS
Fifty-one (83.6%) centers from seven different countries answered the survey. A total of 2887 LLR were performed, as follows: Argentina (928), Brazil (1326), Chile (322), Colombia (210), Paraguay (9), Peru (75), and Uruguay (8). The first program began in 1997; however, the majority (60.7%) started after 2010. The percentage of LLR over open resections was 28.4% (4.4-84%). Of the total, 76.5% were minor hepatectomies and 23.5% major, including 266 right hepatectomies and 343 left hepatectomies. The conversion rate was 9.7%, overall morbidity 13%, and mortality 0.7%.
CONCLUSIONS CONCLUSIONS
This is the largest study assessing the dissemination and results of LLR in South America. It showed an increasing number of centers performing LLR with the promising perioperative results, aligned with other worldwide excellence centers.

Identifiants

pubmed: 32591841
doi: 10.1007/s00268-020-05646-4
pii: 10.1007/s00268-020-05646-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3868-3874

Auteurs

J Pekolj (J)

HPB Surgery Section, General Surgery Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

R Clariá Sánchez (R)

HPB Surgery Section, General Surgery Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

J Salceda (J)

Hospital Ramón Santamarina, Tandil, Argentina.

R J Maurette (RJ)

Hospital Británico, Buenos Aires, Argentina.

P B Schelotto (PB)

Fundación Favaloro, Buenos Aires, Argentina.

L Pierini (L)

Clínica Nefrología, Clínica Uruguay, Hospital Iturraspe, Santa Fe, Argentina.

E Cánepa (E)

Hospital Privado de Comunidad, Mar del Plata, Argentina.

M Moro (M)

Hospital Italiano - Regional Sur, Bahía Blanca, Argentina.

G Stork (G)

Hospital Italiano - Regional Sur, Bahía Blanca, Argentina.

N Resio (N)

Unidad HPB Sur, General Roca, Argentina.

J Neffa (J)

Hospital Italiano de Mendoza, Mendoza, Argentina.

L Mc Cormack (L)

Hospital Alemán, Buenos Aires, Argentina.

E Quiñonez (E)

Hospital El Cruce, Buenos Aires, Argentina.

G Raffin (G)

Hospital Argerich, Buenos Aires, Argentina.

L Obeide (L)

Hospital Universitario Privado, Córdoba, Argentina.

D Fernández (D)

Clínica Pueyrredón, Mar del Plata, Argentina.

G Pfaffen (G)

Sanatorio Güemes, Buenos Aires, Argentina.

C Salas (C)

Sanatorio 9 de Julio, Santiago del Estero, Argentina, Hospital Centro de Salud, San Miguel de Tucumán, Argentina.

M Linzey (M)

Hospital Angel C. Padilla, San Miguel de Tucumán, Argentina.

G Schmidt (G)

Hospital Escuela Gral, Corrientes, Argentina.

S Ruiz (S)

Clínica Colón, Mar del Plata, Argentina.

F Alvarez (F)

Clínica Reina Fabiola, Hospital Italiano, Córdoba, Argentina.

J Buffaliza (J)

Hospital Lagommagiore, Mendoza, Argentina.

R Maroni (R)

Hospital Papa Francisco, Salta, Argentina.

O Campi (O)

Clínica Regional General Pico, Santa Rosa, Argentina.

C Bertona (C)

Hospital Español, Mendoza, Argentina.

M de Santibañes (M)

HPB Surgery Section, General Surgery Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

O Mazza (O)

HPB Surgery Section, General Surgery Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

M Belotto de Oliveira (M)

Hospital Sírio Libanês, São Paulo, Brazil.

A L Diniz (AL)

A.C. Camargo Cancer Center, São Paulo, Brazil.

M Enne de Oliveira (M)

Ipanema Federal Hospital, Rio de Janeiro, Brazil.

M A Machado (MA)

Hospital Sírio Libanês, São Paulo, Brazil.

A N Kalil (AN)

Santa Casa de Porto Alegre, Universidade Federal de Ciências da Saúde, Porto Alegre, Brazil.

R D Pinto (RD)

Hospital Santa Catarina de Blumenau, Blumenau, Brazil.

A P Rezende (AP)

Hospital Mater Dei, Belo Horizonte, Brazil.

E J B Ramos (EJB)

Hospital Nossa Senhora das Graças, Curitiba, Brazil.

A Talvane T Oliveira (A)

Hospital Americas Medical City Hospital Samaritano, Rio de Janeiro, Brazil.

O J M Torres (OJM)

Hospital Universitario HUUFMA, Hospital São Domingos, UDI Hospital, Fortaleza, Brazil.

N Jarufe Cassis (N)

Universidad Católica de Chile, Santiago, Chile.

E Buckel (E)

Clínica Las Condes, Santiago, Chile.

R Quevedo Torres (R)

Hospital de Concepción, Concepción, Chile.

J Chapochnick (J)

Clínica Santa María, Santiago, Chile.

M Sanhueza Garcia (M)

Hospital Sotero del Río, Santiago, Chile.

C Muñoz (C)

Hospital de Talca, Talca, Chile.

G Castro (G)

Hospital de Arica, Arica, Chile.

H Losada (H)

Hospital de Temuco, Temuco, Chile.

F Vergara Suárez (F)

Clínica Vida - Fundación Colombiana de Cancerología, Medellin, Colombia.

O Guevara (O)

Instituto Nacional de Cancerologia, Bogotá, Colombia.

D Dávila (D)

Clínica CES, Medellín, Colombia.

O Palacios (O)

Clínica CES, Medellín, Colombia.

A Jimenez (A)

Hospital Clínicas, Asunción, Paraguay.

L Poggi (L)

Clínica Anglo Americana, Lima, Peru.

V Torres (V)

Hospital Guillermo Almenara ESSALUD, Lima, Peru.

G M Fonseca (GM)

Hospital das Clínicas - University of São Paulo School of Medicine, São Paulo, Brazil.

J A P Kruger (JAP)

Hospital das Clínicas - University of São Paulo School of Medicine, São Paulo, Brazil.

F F Coelho (FF)

Hospital das Clínicas - University of São Paulo School of Medicine, São Paulo, Brazil.

L Russo (L)

Hospital Maciel, Casmu, Montevideo, Uruguay.

P Herman (P)

Hospital das Clínicas - University of São Paulo School of Medicine, São Paulo, Brazil. pherman@uol.com.br.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH